Talmadge, S. v. Ervin, F.

2020 Pa. Super. 176
CourtSuperior Court of Pennsylvania
DecidedJuly 28, 2020
Docket1070 MDA 2019
StatusPublished
Cited by1 cases

This text of 2020 Pa. Super. 176 (Talmadge, S. v. Ervin, F.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Talmadge, S. v. Ervin, F., 2020 Pa. Super. 176 (Pa. Ct. App. 2020).

Opinion

J-A03023-20

2020 PA Super 176

STEVEN L. TALMADGE, ADMINISTRATOR IN THE SUPERIOR COURT OF THE ESTATE OF DEBRA ELIZABETH OF PENNSYLVANIA TALMADGE, DECEASED AND STEVEN L. TALMADGE, INDIVIDUALLY

Appellants

v.

FRANK H. ERVIN, R.PH., CARL'S DRUG STORE, INC., NATHAN DERSTINE, D.O., AND GREENCASTLE FAMILY PRACTICE, P.C.

Appellee No. 1070 MDA 2019

Appeal from the Order Entered June 3, 2019 In the Court of Common Pleas of the 39th Judicial District, Franklin County Branch, Civil Division at No: 2013-04640

BEFORE: LAZARUS, STABILE, JJ., and STEVENS, P.J.E.*

OPINION BY STABILE, J.: FILED JULY 28, 2020

Appellant, Steven L. Talmadge, in his own right and as administrator of

the estate of decedent Debra Elizabeth Talmadge (“Decedent”), appeals from

the June 3, 2019 judgment entered in favor of Appellees, Frank H. Ervin

(“Ervin”), R.PH., Carl’s Drug Store, Inc. (“Carl’s”), Nathan Derstine, D.O. (“Dr.

Derstine”), and Greencastle Family Practice, P.C. (“Greencastle”). We vacate

and remand for a new trial.

____________________________________________

* Former Justice specially assigned to the Superior Court. J-A03023-20

The trial court recited the pertinent facts in its opinion denying post-trial

relief:

The instant medical malpractice action arises from the untimely death of Debra Talmadge on November 29, 2011. At the time of her death, [Decedent] was under the medical care and supervision of [Dr. Derstine], a physician and partner at the [Greencastle].

On November 22, 2012, [Decedent] presented at [Greencastle] with complaints of nausea; she was prescribed and began taking Phenergan in addition to her long-term prescription for Lexapro. On November 25, 2011, five days prior to her death, [Decedent] again sought treatment from Dr. Derstine. Based on [Decedent’s] symptoms, Dr. Derstine suspected pneumonia and prescribed Biaxin.

[Decedent’s] Biaxin prescription was later filled at [Carl’s], by on-duty pharmacist Shane Clugston, under the supervision of [Ervin].

Trial Court Opinion, 6/3/19, at 1-2 (footnotes omitted).

Several days later, Decedent passed away. Appellant filed this medical

malpractice action against all Appellees on November 19, 2013. Appellant

alleged that the interaction between Phenergan, Lexapro, and Biaxin triggered

a condition called prolonged QT syndrome that caused Decedent’s death. The

jury entered a defense verdict on February 13, 2019. Appellant filed a timely

post-trial motion alleging that the trial court erred in granting Appellee’s

pretrial motion in limine, and in finding Appellee’s expert witness to be

qualified to testify in this matter. The trial court denied Appellant’s post-trial

motions on June 3, 2019, and this timely appeal followed.

The following principles govern our review:

-2- J-A03023-20

[O]ur standard of review when faced with an appeal from the trial court’s denial of a motion for a new trial is whether the trial court clearly and palpably committed an error of law that controlled the outcome of the case or constituted an abuse of discretion. In examining the evidence in the light most favorable to the verdict winner, to reverse the trial court, we must conclude that the verdict would change if another trial were granted. Further, if the basis of the request for a new trial is the trial court's rulings on evidence, then such rulings must be shown to have been not only erroneous but also harmful to the complaining parties. Evidentiary rulings which did not affect the verdict will not provide a basis for disturbing the jury's judgment.

Ratti v. Wheeling Pittsburgh Steel Corp., 758 A.2d 695, 707 (Pa. Super.

2000), appeal denied, 785 A.2d 90 (Pa. 2001).

First, Appellant challenges the trial court’s order granting Appellees’ pre-

trial motion in limine to exclude a document contained with the Pennsylvania

State Police report and Appellant’s expert’s testimony as to that document.

We review evidentiary rulings for abuse of discretion. Czimmer v. Janssen

Pharmaceuticals, Inc., 122 A.3d 1043, 1058 (Pa. Super. 2015). The

document in question (the “Pill Count Document”) was an unsigned,

handwritten note indicating that Decedent was prescribed twenty pills of

Biaxin, of which twelve remained in the bottle after her death. The Pill Count

Document was part of the police investigation file, produced in response to

Appellees’ subpoena. The matter arose during the pre-trial recorded

deposition testimony of Appellant’s expert witness, Dr. Douglass Peter Zipes.

The deposition was recorded for use at trial, and was introduced in redacted

form after Appellees’ successful motion in limine.

-3- J-A03023-20

Appellant wished to argue, based on the date of the prescription and the

date of death, that Decedent ingested all eight of the missing pills, which

would have been in accord with the prescribed dosage over that time.

Appellees’ argument was that there was no direct evidence Decedent took

more than one Biaxin; the pill that Appellant saw her ingest. The autopsy

toxicology screen did not reflect Biaxin present (though it is unclear whether

the person conducting the autopsy screened for Biaxin). N.T. Zipes

Deposition, 1/29/19, at 45. No one other than Appellant reported seeing

Decedent take a Biaxin, and he saw her take only one. Id. at 46.

The trial court ruled that the Pill Count Document was hearsay, and that

Appellant did not authenticate it under the business records exception (Pa.R.E.

806) because it was handwritten and unsigned.1 Nonetheless, the trial court

permitted Appellant to attempt to authenticate the Pill Count Document at trial

by calling the State Police Officer who prepared and produced the report.

Appellant did not do so.

Presently, Appellant argues that Appellees’ objections during the

deposition were insufficient to preserve this issue. Appellant relies on Pa.R.E.

103(a)(1), which requires the party opposing the evidence to make a timely

1 We are cognizant that the law permits experts to rely on hearsay in forming their opinions. See Klein v. Aronchick, 85 A.3d 487, 502 (Pa. Super. 2014), appeal denied, 104 A.3d 5 (Pa. 2014). Here, Appellant’s expert did not rely on the Pill Count Document in the preparation of his written report, and Appellant does not argue that the expert was entitled to rely on hearsay in giving his testimony.

-4- J-A03023-20

objection and state the grounds for it. The trial court concluded that counsel

for Dr. Derstine and Greencastle sufficiently preserved this issue in the

following exchange during Dr. Zipes’ examination by counsel for Dr. Derstine,

and Greencastle:

Q. Doctor, I’m looking at the two last paragraphs there that indicate according to the report by Dr. Wayne Ross – and Dr. Wayne Ross is the pathologist hired by the plaintiffs in his case, correct?

A. I think that’s correct, yes.

Q. Not the pathologist that actually did the autopsy in this case.

A. Yes.

Q. What you’re saying is in his report he believes Mrs. Talmadge took one pill on the 25th, the day she got the prescription of Biaxin, correct?

Q. Two pills on the 26th and 27th and one on the 28th.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Talmadge, S. v. Ervin, F.
2020 Pa. Super. 176 (Superior Court of Pennsylvania, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
2020 Pa. Super. 176, Counsel Stack Legal Research, https://law.counselstack.com/opinion/talmadge-s-v-ervin-f-pasuperct-2020.